Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin crossover trial in primary progressive multiple sclerosis
IRCT20100119003106N41Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of clarithromycin in primary progressive multiple sclerosis (PPMS) (2 arms), sponsored by Islamic Azad University. Primary endpoints: TNF-alpha serum level and Quality of life. Started May 2020; status: completed.
02
Drugs
clarithromycin
03
Conditions
primary progressive multiple sclerosis (PPMS)
Beyond the preview
Go deeper on IRCT20100119003106N41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100119003106N41.